CVRx said yesterday that it won a humanitarian device exemption from the FDA for its Barostim neo legacy device, to treat drug-resistant hypertension.
Hypertension
Renal denervation: Analysis highlights ‘confounding’ factors in Medtronic’s Symplicity-3 trial
Vascular Dynamics raises $10m
Vascular Dynamics said it raised nearly $10 million from a group of unnamed investors for the hypertension implant it’s developing.
The Mountain View, Calif.-based startup reported raising $9.7 million in an offering of stock, warrants and other securities as part of a proposed $22.9 million funding round.
Stealth hypertension startup Sympara Medical raises nearly $6m
Ablative Solutions tests infusion ablation catheter as hypertension treatment
TCT 2014: Another trial shows no benefit for renal denervation in hypertension
TCT 2014 Roundup
Medtronic’s renal denervation no better at 1 year, researchers say
Renal denervation isn’t dead, despite Medtronic trial’s failure
Kona Medical launches hypertension trial for non-invasive RDN device
Kona Medical said this week that it’s launched a clinical trial of the non-invasive renal denervation device for treating hypertension it calls Surround Sound.
Can Big Data help detect silent hypertension? | MassDevice.com On Call
MASSDEVICE ON CALL — A computer algorithm may be able to help physicians monitor patients for signs of hypertension, a disease known as "the silent killer."
Researchers at Northwestern Medicine developed a trio of algorithms to review patients’ electronic health records and alert healthcare providers that a patient may have or may be developing hypertension.